Healthcare -
Biotechnology - NASDAQ - US
$ 1.32
6.3 %
$ 841 M
Market Cap
-5.0
P/E
GERN - CASH FROM OPERATIONS
Cash from Operations GERN - Geron Corporation
-219 M
LAST VALUE
-31.01%
2 YEAR CAGR
-37.91%
5 YEAR CAGR
-37.63%
10 YEAR CAGR